Profile: PLC Medical Systems creates products which perform a new surgical procedure known as transmyocardial revascularization (TMR). Our TMR offers a completely new medical treatment option for patients suffering from severe coronary artery disease. Our CO2 heart laser 2 enables the surgeon to make timely operative decisions to revascularize the heart with CO2 TMR. Our RenalGuard Therapy® is designed to reduce the toxic effects that contrast media can have on the kidneys for patients undergoing imaging procedures. This therapy is based on the theory that creating and maintaining a high urine output allows the body to rapidly eliminate contrast, & reducing its toxic effects.
The company was founded in 1987, has revenues of USD 5-10 Million, has ~30 employees and is ISO 9000, CE certified. OTC:PLCSF (SEC Filings)
FDA Registration Number: 1287243
9 Products/Services (Click for related suppliers)
|
• CO2 Surgical Laser System |
• Laser Revasularization Equipment |
• Laser Revasularization Equipment, CO2 |
• Laser Revasularization Equipment, Holmium YAG |
• Powered Surgical Laser Instrument (FDA Code: GEX / 878.4810) (1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide. |
• Transmyocardial Revascularization |
• Transmyocardial Revascularization Laser System (FDA Code: MNO) |
• Used Surgical Lasers |
• Wires and Cables for Surgical Lasers |